BREAKING: Insurance Approving Mounjaro Over Zepbound!? What is Going On!?
https://www.getclaimable.com/otp
Code OTP10 Saves 10%
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
-------- Â
17:34
--------
17:34
Behind the Scenes of the Obesity Drug Battle | Obesity Action Coalition President Interview
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
-------- Â
35:23
--------
35:23
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
https://www.getclaimable.com/otp
Code OTP10 Saves 10%
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
#zepbound #insurance #cvscaremark
-------- Â
33:37
--------
33:37
Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
-------- Â
26:52
--------
26:52
Faces of The Fight: The Jamie Selzler Story
At 650 pounds, GLP-1 injections helped give Jamie His Life Back.
Get Our Newsletter and Help us Grow!
https://www.obesity.news
Support OTP (all our links):
https://linktr.ee/manonthemounjaro
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!